Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition

Carcinogenesis

Volumn 30, Issue 11, 2009, Pages 1898-1902

  García, María J ^a,b   Fernández, Victoria ^a,b   Osorio, Ana ^a,b   Barroso, Alicia ^a,b   Fernández, Fernando ^a,b   Urioste, Miguel ^a,b   Benítez, Javier ^a,b  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; ONCOPROTEIN; PROTEIN FANCI; PROTEIN FANCM; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CROSS LINKING; EXON; FAMILY STUDY; FANCONI ANEMIA; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

BRCA2 PROTEIN; BREAST NEOPLASMS; DNA HELICASES; DNA MUTATIONAL ANALYSIS; EXONS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP L PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; MUTATION;

EID: 70849132066     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp218     Document Type: Article

References (46)

1. Joenje,H. et al. (2001) The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet., 2, 446-457.
2. Tischkowitz,M.D. et al. (2003) Fanconi anaemia. J. Med. Genet. 40, 1-10.
3. Dorsman,J.C. et al. (2007) Identification of the Fanconi anemia complementation group I gene, FANCI. Cell. Oncol., 29, 211-218.
4. Smogorzewska,A. et al. (2007) Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell, 129, 289-301.
5. Sims,A.E. et al. (2007) FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat. Struct. Mol. Biol., 14, 564-567.
6. Wang,W. (2007) Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet., 8, 735-748.
7. Kennedy,R.D. et al. (2005) The Fanconi Anemia/BRCA pathway: New faces in the crowd. Genes Dev., 19, 2925-2940.
8. Howlett,N.G. et al. (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science, 297, 606-609.
9. Seal,S. et al. (2003) Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Cancer Res., 63, 8596-8599.
10. Seal,S. et al. (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat. Genet., 38, 1239-1241.
11. Rahman,N. et al. (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet., 39, 165-167.
12. Garcia,M.J. et al. (2009) Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families. Breast Cancer Res. Treat., 113, 545-551.
13. Tischkowitz,M. et al. (2007) Analysis of PALB2/FANCN-associated breast cancer families. Proc. Natl Acad. Sci. USA, 104, 6788-6793.
14. Erkko,H. et al. (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature, 446, 316-319.
15. Foulkes,W.D. et al. (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res., 9, R83.
16. Erkko,H. et al. (2008) Penetrance analysis of the PALB2 c.1592delT founder mutation. Clin. Cancer Res., 14, 4667-4671.
17. Venkitaraman,A.R. (2004) Tracing the network connecting BRCA and Fanconi anaemia proteins. Nat. Rev. Cancer, 4, 266-276.
18. Alpi,A.F. et al. (2008) Mechanistic insight into site-restricted monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI. Mol. Cell 32, 767-777.
19. Meetei,A.R. et al. (2003) A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet., 35, 165-170.
20. Xue,Y. et al. (2008) FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair. Hum. Mol. Genet. 17, 1641-1652.
21. Collis,S.J. et al. (2008) FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex. Mol. Cell, 32, 313-324.
22. Milne,R.L. et al. (2006) ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping. Cancer Res., 66, 9420-9427.
23. Llort,G. et al. (2002) Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain. Hum. Mutat., 19, 307.
24. Diez,O. et al. (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects. Hum. Mutat., 22, 301-312.
25. de la Hoya,M. et al. (2001) Spanish family study on hereditary breast and/or ovarian cancer: Analysis of the BRCA1 gene. Int. J. Cancer, 91, 137-140.
26. Beristain,E. et al. (2007) Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling. Breast Cancer Res. Treat., 106, 255-262.
27. Osorio,A. et al. (2000) Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br. J. Cancer, 82, 1266-1270.
28. den Dunnen,J.T. et al. (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum. Mutat. 15, 7-12.
29. den Dunnen,J.T. et al. (2003) Standardizing mutation nomenclature: why bother? Hum. Mutat., 22, 181-182.
30. Ng,P.C. et al. (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res., 31, 3812-3814.
31. Ng,P.C. et al. (2002) Accounting for human polymorphisms predicted to affect protein function. Genome Res., 12, 436-446.
32. Ramensky,V. et al. (2002) Human non-synonymous SNPs: Server and survey. Nucleic Acids Res., 30, 3894-3900.
33. Sunyaev,S. et al. (2000) Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet., 16, 198-200.
34. Yeo,G. et al. (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol. 11, 377-394.
35. Pertea,M. et al. (2001) GeneSplicer: A new computational method for splice site prediction. Nucleic Acids Res., 29, 1185-1190.
36. Antoniou,A.C. et al. (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol., 21, 1-18.
37. Gasco,M. et al. (2003) TP53 mutations in familial breast cancer: functional aspects. Hum. Mutat., 21, 301-306.
38. Ball,S. et al. (2001) Breast cancer, Cowden disease and PTEN-MATCHS syndrome. Eur. J. Surg. Oncol., 27, 604-606.
39. Giardiello,F.M. et al. (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology, 119, 1447-1453.
40. Thompson,D. et al. (2005) Two ATM variants and breast cancer risk. Hum. Mutat., 25, 594-595.
41. Meijers-Heijboer,H. et al. (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet., 31, 55-59.
42. Heikkinen,K. et al. (2006) RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis, 27, 1593-1599.
43. Wang,W. (2008) A major switch for the Fanconi anemia DNA damage-response pathway. Nat. Struct. Mol. Biol., 15, 1128-1130.
44. Ishiai,M. et al. (2008) FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. Nat. Struct. Mol. Biol., 15, 1138-1146.
45. Meetei,A.R. et al. (2005) A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet., 37, 958-963.
46. Sun,W. et al. (2008) The FANCM ortholog Fml1 promotes recombination at stalled replication forks and limits crossing over during DNA double-strand break repair. Mol. Cell, 32, 118-128.